SynthesisPaediatric drugs2025

Long-Term Safety of Anti-Interleukin-1 Medications in Children with Rheumatic Diseases: a Systematic Review.

M Isa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.